Payment overview · 2025
General Payments
$71,178.42
106 reported records · 11 companies
Healthcare provider profile · identity verified
Darren B Schneider, MD
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · PHILADELPHIA, PA · NPI 1790741106
Verified facts
What the public records show
CMS Open Payments records show Darren B Schneider, MD received $71,178.42 in general payments during 2025 across 106 reported records.
W. L. Gore & Associates, Inc. accounted for 68.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 43 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $48,960.63 | 68.8% | 66 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $10,039.65 | 14.1% | 15 | 2025 |
| Cook Incorporated | Unresolved — no canonical attribution shown | $5,580.00 | 7.8% | 2 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $4,611.69 | 6.5% | 5 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $1,410.64 | 2.0% | 10 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$254.94 | 0.4% | 2 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $139.17 | 0.2% | 1 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $106.75 | 0.1% | 2 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $35.98 | 0.1% | 1 | 2025 |
| Siemens Medical Solutions USA, Inc. | Unresolved — no canonical attribution shown | $31.50 | 0.0% | 1 | 2025 |
| LifeNet Health | Unresolved — no canonical attribution shown | $7.47 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $40,650.00 | 10 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,830.00 | 7 |
| Food and Beverage | $6,939.84 | 73 |
| Travel and Lodging | $4,758.58 | 16 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Product in Development Normalized: product in development |
Device | W. L. Gore & Associates, Inc. | $20,972.36 | 22 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis Normalized: gore viabahn endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $19,706.04 | 3 | 2025 |
Source payment records
|
|||||
| GORE-TEX Vascular Graft Normalized: gore tex vascular graft |
Device | W. L. Gore & Associates, Inc. | $19,500.00 | 2 | 2025 |
Source payment records
|
|||||
| VIABAHN Endoprosthesis with PROPATEN Bioactive Surface Normalized: viabahn endoprosthesis with propaten bioactive surface |
Device | W. L. Gore & Associates, Inc. | $19,500.00 | 2 | 2025 |
Source payment records
|
|||||
| GORE PROPATEN Vascular Graft Normalized: gore propaten vascular graft |
Device | W. L. Gore & Associates, Inc. | $15,600.00 | 1 | 2025 |
Source payment records
|
|||||
| VIATORR Endoprosthesis Normalized: viatorr endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $15,600.00 | 1 | 2025 |
Source payment records
|
|||||
| AngioJet Ultra 5000A Normalized: angiojet ultra 5000a |
Device | Boston Scientific Corporation | $9,050.00 | 4 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $6,917.35 | 19 | 2025 |
Source payment records
|
|||||
| RUBY Coil Normalized: ruby coil |
Device | Penumbra, Inc. | $4,200.00 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis with Heparin Normalized: gore viabahn endoprosthesis with heparin |
Device | W. L. Gore & Associates, Inc. | $4,052.57 | 2 | 2025 |
Source payment records
|
|||||
| ZENITH ALPHA Normalized: zenith alpha |
Device | Cook Incorporated, Cook Medical LLC | $3,722.11 | 2 | 2025 |
Source payment records
|
|||||
| GORE TAG Thoracic Branch Endoprosthesis Normalized: gore tag thoracic branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $2,745.69 | 10 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Iliac Branch Endoprosthesis Normalized: gore excluder iliac branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $1,412.12 | 2 | 2025 |
Source payment records
|
|||||
| ZENITH SPIRAL-Z Normalized: zenith spiral z |
Device | Cook Medical LLC | $669.10 | 6 | 2025 |
Source payment records
|
|||||
| EXCLUDER Conformable AAA Endoprosthesis with Active Control Normalized: excluder conformable aaa endoprosthesis with active control |
Device | W. L. Gore & Associates, Inc. | $655.62 | 2 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER AAA Endoprosthesis Normalized: gore excluder aaa endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $624.06 | 2 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Normalized: gore excluder thoracoabdominal branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $573.70 | 6 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $332.21 | 3 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $312.56 | 2 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Neuroprotection System Normalized: enroute transcarotid neuroprotection system |
Device | Boston Scientific Corporation | $196.96 | 2 | 2025 |
Source payment records
|
|||||
| TURBOHAWK Normalized: turbohawk |
Device | Medtronic, Inc. | $172.86 | 1 | 2025 |
Source payment records
|
|||||
| Ranger Normalized: ranger |
Device | Boston Scientific Corporation | $168.83 | 1 | 2025 |
Source payment records
|
|||||
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $144.00 | 1 | 2025 |
Source payment records
|
|||||
| GRAFIX PL Normalized: grafix pl |
Biological | Smith+Nephew, Inc. | $139.17 | 1 | 2025 |
Source payment records
|
|||||
| OASIS MICRO Normalized: oasis micro |
Device | Smith+Nephew, Inc. | $139.17 | 1 | 2025 |
Source payment records
|
|||||
| STRAVIX MESH Normalized: stravix mesh |
Biological | Smith+Nephew, Inc. | $139.17 | 1 | 2025 |
Source payment records
|
|||||
| STRAVIX PL Normalized: stravix pl |
Biological | Smith+Nephew, Inc. | $139.17 | 1 | 2025 |
Source payment records
|
|||||
| FORS Other Consumables Normalized: fors other consumables |
Device | Philips North America LLC | $106.75 | 2 | 2025 |
Source payment records
|
|||||
| C3 Delivery System Normalized: c3 delivery system |
Device | W. L. Gore & Associates, Inc. | $102.53 | 1 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $99.13 | 2 | 2025 |
Source payment records
|
|||||
| General - Metallic Stents Normalized: general metallic stents |
Device | Boston Scientific Corporation | $85.53 | 1 | 2025 |
Source payment records
|
|||||
| ENDURANT IIS Normalized: endurant iis |
Device | Medtronic, Inc. | $82.08 | 1 | 2025 |
Source payment records
|
|||||
| ZENITH FLEX Normalized: zenith flex |
Device | Cook Medical LLC | $52.39 | 1 | 2025 |
Source payment records
|
|||||
| General - Vascular Intervention Normalized: general vascular intervention |
Device | Boston Scientific Corporation | $44.89 | 2 | 2025 |
Source payment records
|
|||||
| ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM Normalized: icast covered stent system 6mmx22mmx120cm |
Device | Cook Medical LLC | $37.04 | 1 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Stryker Corporation | $35.98 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Stryker Corporation | $35.98 | 1 | 2025 |
Source payment records
|
|||||
| ARTIS icono biplane Normalized: artis icono biplane |
Device | Siemens Medical Solutions USA, Inc. | $31.50 | 1 | 2025 |
Source payment records
|
|||||
| Artis pheno Normalized: artis pheno |
Device | Siemens Medical Solutions USA, Inc. | $31.50 | 1 | 2025 |
Source payment records
|
|||||
| LUNDERQUIST Normalized: lunderquist |
Device | Cook Medical LLC | $30.00 | 1 | 2025 |
Source payment records
|
|||||
| GORE TAG Conformable Thoracic Endoprosthesis Normalized: gore tag conformable thoracic endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $18.59 | 1 | 2025 |
Source payment records
|
|||||
| ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter Normalized: enroute enflate transcarotid rx balloon dilatation catheter |
Device | Boston Scientific Corporation | $17.23 | 1 | 2025 |
Source payment records
|
|||||
| TheraGenesis Wound Matrix Normalized: theragenesis wound matrix |
Device | LifeNet Health | $7.47 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 20 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $71,178.42 · 106 records | W. L. Gore & Associates, Inc. | ARTIS icono biplane, AngioJet Ultra 5000A, Artis pheno, C3 Delivery System, CT THROMBECTOMY SYSTEM KIT, ELUVIA, ENDURANT IIS, ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter, ENROUTE Transcarotid Neuroprotection System, EXCLUDER Conformable AAA Endoprosthesis with Active Control, FLOWTRIEVER CATHETER, S, FORS Other Consumables, GORE EXCLUDER AAA Endoprosthesis, GORE EXCLUDER Iliac Branch Endoprosthesis, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE PROPATEN Vascular Graft, GORE TAG Conformable Thoracic Endoprosthesis, GORE TAG Thoracic Branch Endoprosthesis, GORE VIABAHN Endoprosthesis, GORE VIABAHN Endoprosthesis with Heparin, GORE VIABAHN VBX Balloon Expandable Endo, GORE-TEX Vascular Graft, GRAFIX PL, General - Metallic Stents, General - Therapies, General - Vascular Intervention, ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM, Indigo System, LUNDERQUIST, OASIS MICRO, Penumbra System, Product in Development, RUBY Coil, Ranger, STRAVIX MESH, STRAVIX PL, TURBOHAWK, TheraGenesis Wound Matrix, VIABAHN Endoprosthesis with PROPATEN Bioactive Surface, VIATORR Endoprosthesis, ZENITH ALPHA, ZENITH FLEX, ZENITH SPIRAL-Z | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error